Breastfeeding Rights-Criso! Hope to Lung Cancer Patients-Dr Higgins!

Shari Criso reminds expectant mothers of their rights in the workplace and offers strategies for breastfeeding success! She shares the results of a survey conducted by Wakefield Research regarding working moms and breast pumps and how Americans stand to lose the benefit of no-cost breastfeeding equipment and support under the Affordable Care Act. World Breastfeeding Week begins Thursday, August 1!

Dr. Kristin Higgins discusses Stage 3 non-small cell lung cancer and an immuno-oncology (IO) therapy called IMFINZI® (durvalumab) the first and only FDA-approved immunotherapy for patients with unresectable, Stage 3 NSCLC. Data released at recent major medical meetiings and a label update from the FDA offers hope to patients with unresectable stage III non-small cell lung cancer.